CL
GSK icon

Choreo LLC’s GSK GSK Stock Holding History

Choreo LLC’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.05M Sell
39,035
-2,271
-5% -$120K 0.02% 408
2026
Q1 		$2.3M Sell
41,306
-2,411
-6% -$131K 0.03% 356
2025
Q4 		$2.16M Sell
43,717
-6,804
-13% -$317K 0.03% 347
2025
Q3 		$2.2M Buy
50,521
+747
+2% +$29.2K 0.03% 351
2025
Q2 		$1.93M Buy
49,774
+1,855
+4% +$70.9K 0.03% 375
2025
Q1 		$1.88M Sell
47,919
-4,832
-9% -$177K 0.03% 349
2024
Q4 		$1.78M Sell
52,751
-1,929
-4% -$69.4K 0.03% 389
2024
Q3 		$2.22M Buy
54,680
+2,523
+5% +$103K 0.03% 329
2024
Q2 		$2M Buy
52,157
+46,088
+759% +$1.94M 0.03% 319
2024
Q1 		$260K Sell
6,069
-1,380
-19% -$56.9K 0.01% 568
2023
Q4 		$279K Buy
7,449
+1,570
+27% +$56.4K 0.01% 512
2023
Q3 		$215K Sell
5,879
-575
-9% -$20.4K 0.01% 434
2023
Q2 		$232K Buy
6,454
+109
+2% +$3.91K 0.01% 420
2023
Q1 		$226K Buy
+6,345
New +$222K 0.01% 442
2018
Q4 		– Sell
-4,618
Closed -$235K – 198
2018
Q3 		$235K Buy
4,618
+414
+10% +$21K 0.03% 193
2018
Q2 		$214K Buy
+4,204
New +$212K 0.03% 221
2017
Q4 		– Sell
-5,154
Closed -$265K – 291
2017
Q3 		$265K Buy
5,154
+948
+23% +$48.1K 0.03% 230
2017
Q2 		$229K Sell
4,206
-17
-0.4% -$906 0.03% 239
2017
Q1 		$226K Sell
4,223
-139
-3% -$7.05K 0.03% 238
2016
Q4 		$212K Buy
4,362
+169
+4% +$8.35K 0.03% 234
2016
Q3 		$228K Buy
+4,193
New +$230K 0.04% 208

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Choreo LLC's GSK Position: Q2 2026 in Review

Choreo LLC reduced its GSK (GSK) stake by 5.5% in Q2 2026, selling an estimated $120K and leaving 39,035 shares worth $2.05M. The position accounts for 0.02% of the portfolio, ranked #408.

Choreo LLC first reported a position in GSK in Q3 2016 and has held it in 21 quarters since. The position peaked at $2.3M in Q1 2026. 1,040 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • Choreo LLC held 39,035 shares of GSK worth $2.05M as of Q2 2026.
  • Choreo LLC sold 2,271 GSK shares in Q2 2026, an estimated $120K.
  • GSK made up 0.02% of Choreo LLC's portfolio in Q2 2026, its #408 holding.
  • Choreo LLC first reported a position in GSK in Q3 2016 and has held it in 21 quarters since.
  • Choreo LLC's GSK position peaked at $2.3M in Q1 2026.
  • 1,040 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Choreo LLC's 13F filing for Q2 2026, filed 4 Aug 2026.